Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.42 USD | +1.74% | -8.81% | -41.69% |
Financials (USD)
Sales 2024 * | 10.19M | Sales 2025 * | 8.11M | Capitalization | 852M |
---|---|---|---|---|---|
Net income 2024 * | -378M | Net income 2025 * | -403M | EV / Sales 2024 * | 66.3 x |
Net cash position 2024 * | 176M | Net cash position 2025 * | 137M | EV / Sales 2025 * | 88.2 x |
P/E ratio 2024 * |
-2.26
x | P/E ratio 2025 * |
-2.24
x | Employees | 309 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.64% |
Latest transcript on Relay Therapeutics, Inc.
1 day | +1.74% | ||
1 week | -8.81% | ||
Current month | -1.53% | ||
1 month | -6.96% | ||
3 months | -29.37% | ||
6 months | -16.19% | ||
Current year | -41.69% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 17-02-28 |
Mark Murcko
FOU | Founder | 64 | 15-05-03 |
Alexis Borisy
FOU | Founder | 52 | 15-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 61 | 19-05-31 |
Linda Hill
BRD | Director/Board Member | 67 | 18-10-08 |
Jami Rubin
BRD | Director/Board Member | 60 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 0 M€ | 0.00% | - | |
0.12% | 2 M€ | -.--% | ||
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 6.42 | +1.74% | 1,407,883 |
24-05-09 | 6.31 | -3.07% | 1,018,499 |
24-05-08 | 6.51 | -3.41% | 979,701 |
24-05-07 | 6.74 | -4.53% | 1,313,128 |
24-05-06 | 7.06 | +0.28% | 629,666 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.69% | 852M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RLAY Stock